¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Active Transport, Cell Nucleus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • centromedian nucleus
    Áß½ÉÁ¤ÁßÇÙ
  • dyad nucleus
    À̺ÐÀÚÇÙ
  • dentate nucleus
    Ä¡¾ÆÇÙ
  • dorsal nucleus of thalamus
    ½Ã»óµîÂÊÇÙ, ½Ã»ó¹èÇÙ
  • Edinger-Westphal nucleus
    ¿¡µù°Å-º£½ºÆ®ÆÈÇÙ, µ¡´«µ¹¸²½Å°æÇÙ
  • emboliform nucleus
    ¸¶°³ÇÙ, Àü»óÇÙ
  • fastigial nucleus
    ²ÀÁöÇÙ
  • facial nucleus
    ¾ó±¼½Å°æÇÙ, ¾È¸é½Å°æÇÙ
  • fertilization nucleus
    ¼öÁ¤ÇÙ
  • flat nucleus
    ÆíÆòÇÙ
  • free nucleus
    À¯¸®ÇÙ
  • fusiform nucleus
    ¹æÃßÇÙ, ¹æÃß»óÇÙ
  • geniculate nucleus
    ¹«¸­ÇÙ, ½½»óÇÙ
  • gigantocellular nucleus
    °Å´ë¼¼Æ÷ÇÙ
  • globose nucleus
    µÕ±ÙÇÙ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • rod cell
    ¸·´ë¼¼Æ÷
  • round cell
    ¿øÇü¼¼Æ÷
  • satellite cell
    À§¼º¼¼Æ÷
  • scavenger cell
    û¼Ò¼¼Æ÷
  • Schwann's cell
    ½Å°æÁý¼¼Æ÷
  • signet ring cell carcinoma
    ¹ÝÁö¼¼Æ÷¾ÏÁ¾
  • signet-ring cell
    ¹ÝÁö¼¼Æ÷
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
  • spindle cell
    ¹æÃß¼¼Æ÷
  • squamous cell carcinoma
    ÆíÆò¼¼Æ÷¾ÏÁ¾
  • squamous cell in situ carcinoma
    ÆíÆò¼¼Æ÷»óÇdz»¾ÏÁ¾, ÆíÆò¼¼Æ÷¾ÏÁ¾
  • stellate cell
    º°¼¼Æ÷
  • stem cell
    Áٱ⼼Æ÷
  • supporting cell
    ¹öÆÀ¼¼Æ÷
  • sustentacular cell
    (¢¡supporting cell) ¹öÆÀ¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • atomic nucleus
    ¿øÀÚÇÙ
  • bacilliform nucleus
    ¸·´ëÇÙ
  • cartwheel nucleus
    ¼ö·¹¹ÙÄûÇÙ, Â÷·ûÇÙ
  • caudate nucleus
    ²¿¸®ÇÙ
  • central nucleus
    Áß½ÉÇÙ
  • central lateral nucleus
    °¡ÂÊÁß½ÉÇÙ
  • central medial nucleus
    ¾ÈÂÊÁß½ÉÇÙ
  • centromedian nucleus
    Áß½ÉÁ¤ÁßÇÙ
  • cleavage nucleus
    ºÐÇÒÇÙ
  • cochlear nucleus
    ´ÞÆØÀÌÇÙ
  • commissural nucleus
    ¸Â±³Â÷ÇÙ
  • cuneate nucleus
    ½û±âÇÙ
  • dentate nucleus
    Ä¡¾ÆÇÙ
  • dyad nucleus
    À̺ÐÀÚÇÙ
  • Edinger-Westphal nucleus
    (¢¡accessory oculomotor nucleus) µ¡´«µ¹¸²½Å°æÇÙ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • anterior cochlear nucleus
    ¾Õ´ÞÆØÀÌÇÙ
  • anterior hypothalamic nucleus
    ¾Õ½Ã»óÇϺÎÇÙ
  • anterior paraventricular nucleus
    ¾Õ³ú½Ç°çÇÙ
  • anterior trapezoid nucleus
    ¾Õ¸¶¸§¼¶À¯Ã¼ÇÙ
  • anterior ventral nucleus
    ¾Õ¹èÂÊÇÙ
  • anterolateral nucleus
    ¾Õ°¡ÂÊÇÙ
  • anteromedial nucleus
    ¾Õ¾ÈÂÊÇÙ
  • anular nucleus
    °í¸®ÇÙ
  • arcuate nucleus
    ±Ã»óÇÙ(ÏáßÒú·)
  • arcuate nucleus
    Ȱ²ÃÇÙ
  • free nucleus
    À¯¸®ÇÙ(ë´ìÆú·).
  • fusiform nucleus
    ¹æÃßÇÙ
  • gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
  • globose nucleus
    µÕ±ÙÇÙ
  • gracile nucleus
    ³ÎÆÇ´Ù¹ßÇÙ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • facilitated transport
    ÃËÁø¼ö¼Û(¡­âÃáê).
  • gas transport
    °¡½º¿î¹Ý(ê¡Úæ).
  • glucose transport protein unit
    Æ÷µµ´ç ¿î¹Ý ´Ü¹é ´ÜÀ§(GLUT)
  • lipid transport
    ÁöÁú¿î¼Û
  • medium, transport
    ¼ö¼Û¹èÁö
  • membrane transport
    ¼¼Æ÷¸·À» ÅëÇÑ À̵¿.
  • net transport
    ¼ø¿î¹Ý.
  • oxygen transport
    »ê¼Ò¿î¹Ý(¡­¿î¹Ý).
  • oxygen transport
    »ê¼Ò¿î¹Ý(¡­ê¡Úæ).
  • oxygen transport mechanism
    »ê¼Ò¿î¹Ý ±âÀü.
  • passive transport
    Çǵ¿Àû ¿î¹Ý(¡­ê¡Úæ).
  • piece, transport
    ¿î¹Ý¼ººÐ, ¼ö¼Û¼ººÐ
  • plasma membrane carnitine transport defect
  • sodium transport system
    ³ªÆ®·ý¿î¹Ý°è (¡­ê¡ÚæÍ§).
  • specimen transport
    °Ëü¼ö¼Û
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Posterior perivenricular nucleus
    µÚ³ú½ÇÁÖÀ§ÇÙ
    [¿¾ ¿ë¾î] ÈĽǹæÇÙ
  • Posterior cochlear nucleus
    µÚ´ÞÆØÀÌÇÙ
    [¿¾ ¿ë¾î] ÈĿͿì½Å°æÇÙ
  • Posterior accessory olivary nucleus
    µÚµ¡¿Ã¸®ºêÇÙ
    [¿¾ ¿ë¾î] Èĺοø®ºêÇÙ
  • Posterior dorsal nucleus
    µÚµîÂÊÇÙ
    [¿¾ ¿ë¾î] ÈĹèÃøÇÙ
  • Posterior trapezoid nucleus
    µÚ¸¶¸§¼¶À¯Ã¼ÇÙ
    [¿¾ ¿ë¾î] ÈÄ´ÉÇüüÇÙ
  • Posterior ventral nucleus
    µÚ¹èÂÊÇÙ
    [¿¾ ¿ë¾î] Èĺ¹ÃøÇÙ
  • Nucleus raphe posterior
    µÚ¼Ö±âÇÙ
    [¿¾ ¿ë¾î] ÈĺÀ¼±ÇÙ
  • Posterior hypothalamic nucleus
    µÚ½Ã»óÇϺÎÇÙ
    [¿¾ ¿ë¾î] ÈĽûóÇϺÎÇÙ
  • Posteromedial ventral nucleus
    µÚ¾ÈÂʹèÂÊÇÙ
    [¿¾ ¿ë¾î] Èij»Ãøº¹ÃøÇÙ
  • Posteromedial nucleus
    µÚ¾ÈÂÊÇÙ
    [¿¾ ¿ë¾î] Èij»ÃøÇÙ
  • Posterior paramedian nucleus
    µÚÁ¤Áß°çÇÙ
    [¿¾ ¿ë¾î] ÈÄÁ¤Áß¹æÇÙ
  • Dorsal hypothalamic nucleus
    µîÂʽûóÇϺÎÇÙ
    [¿¾ ¿ë¾î] ¹èÃø½Ã»óÇϺÎÇÙ
  • Dorsomedial hypothalamic nucleus
    µîÂʾÈÂʽûóÇϺÎÇÙ
    [¿¾ ¿ë¾î] ¹è³»Ãø½Ã»óÇϺÎÇÙ
  • Medial dorsal nucleus
    µîÂʾÈÂÊÇÙ
    [¿¾ ¿ë¾î] ¹èÃø³»ÃøÇÙ
  • Paratenial nucleus
    ¶ì°çÇÙ
    [¿¾ ¿ë¾î] ²ö¹æÇÙ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • active hydroxyethyl
    Ȱ¼º(üÀàõ)ÇÏÀ̵å·Ï½Ã¿¡Æ¿
  • active hydroxymethyl
    Ȱ¼º(üÀàõ)ÇÏÀ̵å·Ï½Ã¸ÞÆ¿
  • active immunity
    ´Éµ¿¸é¿ª(ÒöÔÑØóæ¹)
  • active iodine
    Ȱ¼º(üÀàõ)¿äµå
  • active methionine
    Ȱ¼º(üÀàõ)¸ÞŸÀÌ¿À´Ñ
  • active methyl
    Ȱ¼º(üÀàõ)¸ÞÆ¿
  • active patch
    Ȱ¼º(üÀàõ)ÆÖÄ¡
  • active phosphate
    Ȱ¼ºÀλ꿰 (üÀàõ ×òß«ç¤)
  • active phospholipid
    Ȱ¼ºÀÎÁöÁú (üÀàõ×òò·òõ)
  • active pyrophosphate
    Ȱ¼º(üÀàõ)ÇÇ·ÎÀλ꿰 (×òß«ç¤)
  • active pyruvate
    Ȱ¼º(üÀàõ)ÆÄÀÌ·çºê»ê¿° (ß«ç¤)
  • active site
    Ȱ¼º(üÀàõ)ÀÚ¸®
  • active site-directed irreversible inhibitor
    Ȱ¼º(üÀàõ)ÀÚ¸®ÁöÇâÀû ºÒ°¡¿ªÀúÇØÁ¦(ò¦ú¾îÜÝÕʦæ½îÁúªð¥)
  • active sulfate
    Ȱ¼ºÈ²»ê¿° (üÀàõüÜß«ç¤)
  • active translocation
    Ȱ¼ºÀüÀ§ (üÀàõï®êÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • red blood cell
    ÀûÇ÷±¸
  • reticulum cell
    ¼¼¸Á¼¼Æ÷
  • reticulum cell sarcoma
    ¼¼¸Á¼¼Æ÷À°Á¾
  • round cell
    ¿øÇü¼¼Æ÷
  • sickle-cell anemia
    °â»ó(Àû)Ç÷±¸¼ººóÇ÷
  • signet-ring cell
    ¹ÝÁö¼¼Æ÷, ÀÎȯ¼¼Æ÷
  • small cell
    ¼Ò¼¼Æ÷
  • small cleaved cell
    ¼ÒºÐÇÒ¼¼Æ÷
  • spindle cell
    ¹æÃ߻󼼯÷
  • squamous cell carcinoma
    ÆíÆò¼¼Æ÷¾ÏÁ¾
  • stem cell
    °£¼¼Æ÷
  • stromal cell
    °£Áú¼¼Æ÷
  • T cell ¡ìthymus derived lymphocyte¡í
    T¼¼Æ÷ ¡ì Èä¼±À¯·¡ ¸²ÇÁ±¸¡í
  • tumor cell
    Á¾¾ç¼¼Æ÷
  • white blood cell
    ¹éÇ÷±¸
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
ARC accelerating rate calorimetry; acquired immunodeficiency syndrome-related complex; active renin conc...
NPC nasopharyngeal carcinoma; near point of convergence; nodal premature contractions; nonparenchymal [l...
Tm maximum Tubular Transport
CPT carnitine palmityl transferase; carotid pulse tracing; chest physiotherapy; child protection team; c...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
AO Active oxygen
AOF Active oxygen forms
AOS Active oxygen species
AR Active renin
AT Active tension
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nociceptive relay nucleus
    À¯ÇØ ¼ö¿ë¼º Áß°è ÇÙ, Ä§ÇØ¼ö¿ë¼º Áß°è ÇÙ
  • nucleus accessorius
    ºÎ½Å°æ ÇÙ
  • nucleus ambiguus
    Àǹ® ÇÙ, ÀÇÇÙ
    ¹ÌÁÖ ½Å°æ, ¼³ÀÎ ½Å°æ ¹× ºÎ½Å°æÀÇ ¿îµ¿ ¼¶À¯¿¡ ±â½ÃµÈ ÇÙÀ¸·Î¼­ ÈÄµÎ¿Í ÀεÎÀÇ È¾¹®±ÙÀ» Áö¹èÇÑ´Ù. ¿¬¼öÀÇ ¹Ì´Ü°ú ¼³ÀÎ ½Å°æÀÇ Ãⱸ ºÎÀ§ »çÀÌ¿¡¼­ ¿¬¼öÀÇ Ãà»èÀÇ Áß°£¿¡ ÀÖ´Â ´Ü¼ÓÀûÀÎ ¼¼Æ÷ÁÖ·Î ÀÌ·ç¾îÁø´Ù.
  • nucleus anterodorsalis
    ¾Õ µîÂÊ ÇÙ, Àü¹èÃø ÇÙ
  • nucleus anteroventralis
    ¾Õ ¹èÂÊ ÇÙ, Àüº¹Ãø ÇÙ
  • nucleus caudalis neuron
    ¹ÌÃø ½Å°æ ÇÙ ´º¿ì·±
    µ¿¾È ½Å°æ ÇÙ º¹ÇÕüÀÇ ¹ÌÃø 1/3¿¡ ÀÖ´Â ºñ´ëĪÀûÀÎ ½Å°æ¿øÀÇ Áý´Ü.
  • nucleus centralis thalami
    ½Ã»ó Á᫐ ÇÙ
  • nucleus colliculi caudalis
    ¾Æ·¡ µÐ´ö ÇÙ, Çϱ¸ ÇÙ
    Çϱ¸ÀÇ ´ëºÎºÐÀ» ÀÌ·ç´Â Å« ³­¿øÇüÀÇ ½Å°æ ¼¼Æ÷ Áý´Ü.
  • nucleus colliculi rostralis
    À§ µÐ´ö ÇÙ, »ó±¸ ÇÙ
  • nucleus corporis geniculati medialis
    ³»Ãø ¹«¸­ ÇÙ, ³»Ãø ½½»óü ÇÙ
    ³»Ãø ½½»óü ³»¿¡ ÀÖ´Â ÇÙÀ¸·Î¼­, »óÇ༺ û°¢ ¼¶À¯¸¦ ¹Þ°í ÇÇÁú û°¢ ÁßÃß·Î ¹æ»çÇÏ´Â Á߽ɺΠ¹× ¹èÃøºÎ·Î ÀÌ·ç¾îÁø´Ù.
  • nucleus dentatus
    Ä¡¾Æ ÇÙ, Ä¡»ó ÇÙ
    Àü»ó ÇÙÀÇ ¹Ù·Î ¿ÜÃø¿¡¼­ ¼Ò³úÀÇ È¸¹éÁú¿¡ ÀÖ´Â ½ÉºÎ ¼Ò³ú ÇÙÀÇ °¡Àå Å« °ÍÀ¸·Î¼­, ½Å ¼Ò³ú¿¡¼­ Purkinje ¼¼Æ÷ ¼¶À¯¸¦ ¹Þ´Â´Ù. ±× Ãà»èÀº »ó ¼Ò³ú °¢ÀÇ ´ëºÎºÐÀ» Çü¼ºÇϰí ÁÖ°í ¹Ý´ëÃøÀÇ ÀûÇÙ ¹× ½Ã»óÀ¸·Î ¹æ»çÇÑ´Ù.
  • nucleus dorsalis nervi glossopharyngei
    ¼³ÀÎ ½Å°æ µîÂÊ ÇÙ, ¼³ÀÎ ½Å°æ ¹èÃø ÇÙ
    ¹ÌÁÖ ½Å°æ¹èÃø ÇÙÀÇ µÎÃø ±Ø. ÀϺÎÀÇ ºÎ±³°¨¼º ¼¶À¯ Áß ¼³ÀÎ ½Å°æÀ¸·Î º¸³»´Â °ÍÀ¸·Î ¹Ï¾îÁø´Ù. ÀϺΠÇÐÀÚ´Â ÀÌ ÇÙ°ú ÇÏŸ¾× ÇÙÀÌ °°´Ù°í ÇÑ´Ù.
  • nucleus dorsolateralis
    µîÂÊ ¿ÜÃø ÇÙ, ¹è¿ÜÃø ÇÙ
    µ¿¾È ½Å°æ ÇÙ º¹ÇÕüÀÇ ¿ÜÃø¿¡¼­ ¹èºÎ¿¡ ÀÖ´Â ¼¼Æ÷·Î¼­, º¹ÇÕüÀÇ 1/3À§Ä¡ÀÇ º¹ºÎ¿¡ ÀÖ´Â ¼¼Æ÷¿Í´Â ¸Å¿ì ´Ù¸£°í, ü¿îµ¿ ±â´ÉÀ» °®´Â´Ù.
  • nucleus emboliformis
    ½û±â ÇÙ, Àü»ó ÇÙ
    Ä¡»ó ÇÙ°ú ±¸»ó ÇÙ »çÀÌ¿¡ ÀÖ´Â ¼Ò³ú·Î¼­, »ó¼Ò³ú °¢¿¡ À̹ÙÁöÇÑ´Ù.
  • nucleus funiculi cuneati
    ¼³»ó ¼Ó ÇÙ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
active inflammation Any inflammation that has a fairly rapid onset, quickly becomes severe, usually manifested for only a few days, but may persist for several days or even a few weeks.
Synonym: active inflammation.
(05 Mar 2000)
active labour Contractions resulting in progressive effacement and dilation of the cervix.
(05 Mar 2000)
active length-tension curve The relationship between active isometric tension and preload (rest length) for a contracting muscle.
(05 Mar 2000)
active metal <chemistry> Any very reactive metal, such as magnesium or sodium, most are located in the first two columns of the periodic table.
(15 Jan 1998)
active methionine S-(5'-deoxy-5'-adenosyl)-l-methionine;condensation product of adenosine and l-methionine involving replacement of the -OPO3H2 of adenylic acid by -S+ (CH3)CH2CH2CH(NH3+)CO 2 of methionine; a sulfonium compound bearing a methyl group that is transferred in transmethylation reactions.
See: methionine adenosyltransferase.
Synonym: active methionine.
Acronym: SAM
(05 Mar 2000)
active methyl A methyl group attached to a quaternary ammonium ion or a tertiary sulfonium ion that can take part in transmethylation reactions; e.g., methyl groups in choline and in S-adenosyl-l-methionine, which are thus methyl donors.
(05 Mar 2000)
active movement Movement effected by the organism itself, unaided by external influences.
(05 Mar 2000)
active mutant A mutant with overt phenotypic expression.
(05 Mar 2000)
active placebo <pharmacology> Any dummy medical treatment, originally, a medicinal preparation having no specific pharmacological activity against the patients illness or complaint given solely for the psychophysiological effects of the treatment, more recently, a dummy treatment administered to the control group in a controlled clinical trial in order that the specific and non-specific effects of the experimental treatment can be distinguished i.e., the experimental treatment must produce better results than the placebo in order to be considered effective.
(18 Nov 1997)
active principle A constituent of a drug, usually an alkaloid or glycoside, upon the presence of which the characteristic therapeutic action of the substance largely depends.
(05 Mar 2000)
active prophylaxis Use of an antigenic (immunogenic) agent to actively stimulate the immunological mechanism.
(05 Mar 2000)
active psychoanalysis Psychoanalysis in which the analyst intervenes directly and actively in the patient's life, e.g., by making prohibitions, assigning tasks.
(05 Mar 2000)
active pyruvate An intermediate formed in the oxidative decarboxylation of pyruvate.
Compare: pyruvate dehydrogenase (lipoamide).
Synonym: alpha-lactyl-thiamin pyrophosphate.
(05 Mar 2000)
active repressor A repressor that combines directly with an operator gene to repress the operator and its structural genes, thus repressing protein synthesis; active repressor may be repressed by an inducer, with resulting protein synthesis; a homeostatic mechanism for regulation of inducible enzyme systems.
(05 Mar 2000)
active site <chemistry> A specific region of an enzyme where a substrate binds and catalysis takes place (binding site).
(06 May 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • voltaic cell
    ÀüÁö
  • wet cell
    ½ÀÀüÁö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á